Covenant Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Covenant Asset Management, LLC

$631 Million
Q3 2024

A detailed history of Covenant Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Covenant Asset Management, LLC holds 6,343 shares of REGN stock, worth $4.8 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

6,343

Previous 6,350 0.11%

Holding current value

$4.8 Million

Previous $6.67 Million 0.09%

% of portfolio

1.06%

Previous 1.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $7,168 - $8,412	-7 Reduced 0.11%	6,343 $6.67 Million
Q2 2024 Aug 02, 2024	SELL	$883.2 - $1071.19 $4,416 - $5,355	-5 Reduced 0.08%	6,350 $6.67 Million
Q1 2024 Apr 23, 2024	SELL	$902.69 - $993.35 $9,929 - $10,926	-11 Reduced 0.17%	6,355 $6.12 Million
Q4 2023 Jan 22, 2024	BUY	$775.18 - $881.7 $172,089 - $195,737	222 Added 3.61%	6,366 $5.59 Million
Q3 2023 Oct 31, 2023	BUY	$692.45 - $844.37 $1.34 Million - $1.64 Million	1,940 Added 46.15%	6,144 $5.06 Million
Q2 2023 Jul 12, 2023	BUY	$700.03 - $830.35 $2.66 Million - $3.16 Million	3,804 Added 951.0%	4,204 $3.02 Million
Q4 2022 Jan 24, 2023	SELL	$705.89 - $766.39 $20.2 Million - $22 Million	-28,660 Reduced 98.62%	400 $0
Q3 2022 Nov 03, 2022	BUY	$573.97 - $724.32 $11.8 Million - $14.9 Million	20,572 Added 242.37%	29,060 $3.93 Million
Q2 2022 Jul 21, 2022	SELL	$548.35 - $738.84 $1.71 Million - $2.3 Million	-3,114 Reduced 26.84%	8,488 $5.02 Million
Q1 2022 Apr 29, 2022	SELL	$595.12 - $698.43 $216,623 - $254,228	-364 Reduced 3.04%	11,602 $8.1 Million
Q4 2021 Jan 26, 2022	SELL	$543.48 - $670.97 $7,065 - $8,722	-13 Reduced 0.11%	11,966 $7.56 Million
Q3 2021 Oct 15, 2021	BUY	$574.03 - $680.96 $119,398 - $141,639	208 Added 1.77%	11,979 $7.25 Million
Q2 2021 Jul 21, 2021	BUY	$472.8 - $558.54 $5.11 Million - $6.03 Million	10,800 Added 1112.26%	11,771 $6.58 Million
Q2 2020 Jul 24, 2020	SELL	$493.32 - $643.92 $165,262 - $215,713	-335 Reduced 25.65%	971 $605,000
Q4 2019 Jan 24, 2020	SELL	$274.13 - $376.51 $7,127 - $9,789	-26 Reduced 1.95%	1,306 $490,000
Q3 2019 Oct 18, 2019	SELL	$273.46 - $318.39 $63,989 - $74,503	-234 Reduced 14.94%	1,332 $369,000
Q2 2019 Jul 17, 2019	SELL	$299.6 - $414.82 $36,551 - $50,608	-122 Reduced 7.23%	1,566 $490,000
Q1 2019 Apr 26, 2019	BUY	$372.08 - $439.57 $294,687 - $348,139	792 Added 88.39%	1,688 $693,000
Q3 2018 Oct 09, 2018	SELL	$351.14 - $408.51 $7,725 - $8,987	-22 Reduced 2.4%	896 $362,000
Q2 2018 Jul 12, 2018	SELL	$284.6 - $344.99 $14,230 - $17,249	-50 Reduced 5.17%	918 $317,000
Q1 2018 May 04, 2018	SELL	$315.82 - $393.78 $944,933 - $1.18 Million	-2,992 Reduced 75.56%	968 $333,000
Q4 2017 Jan 12, 2018	SELL	$358.63 - $469.95 $26,897 - $35,246	-75 Reduced 1.86%	3,960 $1.49 Million
Q3 2017 Oct 19, 2017	BUY	$431.38 - $504.0 $1.74 Million - $2.03 Million	4,035	4,035 $1.8 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.

Account

Covenant Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History